Estrogen plus progestin therapy does not prevent mild cognitive impairment (MCI) in women aged 65 years and older, and it increases the risk for probable dementia in this group, according to researchers from the Women's Health Initiative Memory Study (WHIMS).

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Estrogen plus progestin therapy increases the risk for probable dementia

Newsletter